SEDOR PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, January 27, 2016, a trademark application was filed for SEDOR PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SEDOR PHARMACEUTICALS trademark a serial number of 86887837. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 24, 2017. This trademark is owned by Rodes Inc.. The SEDOR PHARMACEUTICALS trademark is filed in the Advertising, Business and Retail Services category with the following description:

business consulting services, namely, pharmaceutical product commercialization
sedor pharmaceuticals

General Information

Serial Number86887837
Word MarkSEDOR PHARMACEUTICALS
Filing DateWednesday, January 27, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 24, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and Servicesbusiness consulting services, namely, pharmaceutical product commercialization

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, February 1, 2016
Primary Code035
First Use Anywhere DateSunday, January 31, 2016
First Use In Commerce DateSunday, January 31, 2016

Trademark Owner History

Party NameRodes Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPaoli, PA 19301

Trademark Events

Event DateEvent Description
Monday, April 24, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 24, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, September 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 22, 2016NON-FINAL ACTION E-MAILED
Thursday, September 22, 2016NON-FINAL ACTION WRITTEN
Wednesday, September 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 13, 2016NON-FINAL ACTION E-MAILED
Tuesday, September 13, 2016NON-FINAL ACTION WRITTEN
Wednesday, September 7, 2016AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, September 7, 2016USE AMENDMENT FILED
Tuesday, September 6, 2016TEAS AMENDMENT OF USE RECEIVED
Thursday, May 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2016NON-FINAL ACTION E-MAILED
Thursday, May 12, 2016NON-FINAL ACTION WRITTEN
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Monday, February 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 30, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals sedor product commercialization pharmaceutical namely consulting services business